Artificial intelligence and machine learning approaches for drug design: challenges and opportunities for the pharmaceutical industries

Abstract

The global spread of COVID-19 has raised the importance of pharmaceutical drug development as intractable and hot research. Developing new drug molecules to overcome any disease is a costly and lengthy process, but the process continues uninterrupted. The critical point to consider the drug design is to use the available data resources and to find new and novel leads. Once the drug target is identified, several interdisciplinary areas work together with artificial intelligence (AI) and machine learning (ML) methods to get enriched drugs. These AI and ML methods are applied in every step of the computer-aided drug design, and integrating these AI and ML methods results in a high success rate of hit compounds. In addition, this AI and ML integration with high-dimension data and its powerful capacity have taken a step forward. Clinical trials output prediction through the AI/ML integrated models could further decrease the clinical trials cost by also improving the success rate. Through this review, we discuss the backend of AI and ML methods in supporting the computer-aided drug design, along with its challenge and opportunity for the pharmaceutical industry. Graphic abstract From the available information or data, the AI and ML based prediction for the high throughput virtual screening. After this integration of AI and ML, the success rate of hit identification has gained a momentum with huge success by providing novel drugs.

Role of Metal Cations of Copper, Iron, and Aluminum and Multifunctional Ligands in Alzheimer’s Disease: Experimental and Computational Insights

“…In addition, emerging tools such as artificial intelligence and machine learning models have been used to speed up and improve the screening process in computer-aided drug design. 160 A proposed computational protocol is presented in Scheme 3. 146,161 The strategy starts with the rational drug design of a structure that should present desirable properties, in addition to metal chelation, which will be used as a reference scaffold.…”

Integrating the new age of bioeconomy and Industry 4.0 into biorefinery process design

“…Besides, the integration of AI methods could mean a high success rate in the development of new compounds. In addition, AI is a powerful tool for developing clinical trial output prediction; this further decreases the clinical trials cost by improving the success rate (Sahu et al 2021;Selvaraj et al 2021).…”

Data-Driven Analytics Leveraging Artificial Intelligence in the Era of COVID-19: An Insightful Review of Recent Developments

“…In addition, there is a chance of improvising each AI technique on COVID-19 data that is relatively new and requires ample work to make sense of it. Besides the AI use in the five different perspectives cited above, AI/ML has also been extensively used in computer-aided drug design and repurposing existing drugs against COVID-19 receptor proteins [86,87]. Monteleone et al [88] discussed the role of AI in drug repurposing with therapeutics analysis for treating infected individuals with COVID-19.…”